Eugenio Battaglia

Eugenio Battaglia

Oct 17, 2014

Group 6 Copy 355
0
    Please wait...

    About This Project

    BioPeers – Peers Center for Biotech and Society
    Our bodies produce very low doses of N,N-Dimethyltryptamine (DMT), a psychotropic substance. Recent findings suggest that DMT is an important modulator of Sig-1R, a receptor that plays important roles in neuropsychiatric diseases like schizophrenia, and depression. This project aims to further develop a hypothesis for the relation between DMT and Sig-1R, in hopes of providing novel insight into these neuropsychiatric diseases.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Developing a new treatment for Ebola Virus Disease

    Ebola is now a threat of global significance. Fatalities are a consequence of the human body's overreactive...

    The Down Low: Curbing the HIV Epidemic in Rural Louisiana

    African American men who have sex with men (MSMs) are at higher risk for new HIV infections in rural communities...

    Do fungi exposed to toxic waste produce novel antimicrobial agents?

    We've discovered a few new mushrooms thriving in this harsh environment of land-disposed sewage sludge in...

    Backer Badge Funded